TW Pengu Holdings Ltd.

The Hong Kong Private Equity group led a cross-office Goodwin team on advising Templewater and its portfolio company TW Pengu Holdings Limited (“TWPHL”), on their acquisitions of: TWPHL’s objective is to develop a premier oncology group in Asia to attract leading doctors and practices across multiple jurisdictions to enable patients to receive the best treatment and services across all stages of the treatment journey. With Templewater’s support, it has expanded its portfolio to include well-known oncology businesses that provide the highest standards of patient service. In December 2023, TWPHL was set up following the acquisition of OncoCare, one of the most established private oncology specialist centers in Singapore, and Novena Heart Centre, one of the leading private cardiology care practices in Singapore. The Goodwin Hong Kong team advised on the acquisitions. Templewater is an alternative asset management firm headquartered in Hong Kong. Templewater provides investment solutions to institutions, entrepreneurs, and family offices across various asset classes including private equity, impact investing, and real estate. Its private equity strategy focuses on mid-market control buyout opportunities in the Asia Pacific. The Goodwin team was led by Edwin Chan and included Samson Peng, with support from Steve Howard, Dora Cheung (Debt Finance), David Chen (Life Sciences/Privacy/IP), Dulcie Daly (Tax), Ce “Charles” Li (Global Trade), William Stern (Financial Services) and Ai Tajima (Risk Management & Insurance). For more details on the investment, please read the press release.

(10 May 2024, Singapore) Templewater, a leading private equity firm specializing in mid-market control buyout opportunities in the Asia Pacific, is pleased to announce that its portfolio company, TW Pengu Holdings Limited (“TWPHL”), has acquired Singapore Breast Surgery Center (“SBSC”), Central Luzon Integrated Oncology Centre (“CLIOC”) and Can-Care from TE Asia Healthcare, a pan-Asia focused healthcare services company. TWPHL’s objective is to develop a premier oncology group in Asia to attract leading doctors and practices across multiple jurisdictions to enable patients to receive the best treatment and services across all stages of the treatment journey. With Templewater’s support, it has expanded its portfolio to include well-known oncology businesses that provide the highest standards of patient service. In December 2023, TWPHL was set up following the acquisition of OncoCare, one of the most established private oncology specialist centers in Singapore, and Novena Heart Centre, one of the leading private cardiology care practices in Singapore. Additionally in February 2024, OncoCare announced the execution of a Letter of Intent with Thomson Hospital Kota Damansara for exclusive negotiations regarding the provision of oncology services in Kuala Lumpur, Malaysia. Today, TWPHL announces three additional acquisitions: · Singapore Breast Surgery Center (“SBSC”) is an integrated breast cancer care group in Singapore, through its brands Solis and Luma, covering the entire breast cancer theragnostic process including screening, diagnostic imaging, pathology and surgery services. · Central Luzon Integrated Oncology Centre (“CLIOC”) is a leading oncology clinic located in Mother Teresa of Calcutta Medical Center in San Fernando, Philippines, providing tomotherapy and chemotherapy services. · Can-Care is a retailer and distributor of post-cancer care products, operating out of four retail outlets in Singapore and Malaysia as well as 22 distributor outlets. Templewater is committed to support TWPHL in achieving its goals to establish itself as the premier oncology focused care group in Asia. We are excited about the future of TWPHL and its potential to make a meaningful impact on the lives of patients across the region. As it expands its footprint, enhances patient offering, and attracts top healthcare talent, Templewater and TWPHL are poised to revolutionize oncology care in Asia and set new standards of excellence in the industry.